7DHL: FGFR3 in 3D

Crystal structure of FGFR3 in complex with pyrimidine derivative. Determined by X-ray diffraction at 2.57 Å resolution. Released 3 Feb 2021.

Method
X-ray diffraction
Resolution
2.57 Å
Organism
Homo sapiens
Chains
1
Atoms
2,361
Mol. weight
36.21 kDa
Ligands
H6X
Released
3 Feb 2021

Explore 7DHL in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

7DHL contains 17 α-helices and 14 β-strands across 1 chain. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 17 helices, 14 β-strands

ElementResiduesLengthSheet
β-strand46611
α-helix469-4713
β-strand472-48091
β-strand485-49281
β-strand502-50981
α-helix516-53217
β-strand53812
α-helix539-5402
β-strand541-54551
β-strand552-55651
α-helix557-5582
β-strand56212
α-helix563-5697
α-helix591-61020
β-strand613-61423
α-helix620-6223
β-strand623-62532
β-strand631-63332
β-strand640-64123
β-strand648-64924
α-helix658-6603
α-helix663-6675
β-strand670-67124
α-helix673-68816
α-helix692-6932
α-helix700-7089
α-helix713-7164
α-helix721-7299
α-helix735-7373
α-helix739-7402
α-helix741-75414

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Fibroblast growth factor receptor 3Aprotein313Homo sapiensP22607 (AlphaFold model)
Sequence of entity 1 (A), FASTA
>7DHL_1 Fibroblast growth factor receptor 3 (chains A)
GSHMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVA
VKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREF
LRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT
EDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE
IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVE
DLDRVLTVTSTDE

Ligands and cofactors

IDNameFormulaCopies
H6X5-[2-(3,5-dimethoxyphenyl)ethyl]-N-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)pipe…C31 H42 N6 O31

Primary citation

Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency. Kuriwaki, I., Kameda, M., Iikubo, K. et al. Bioorg Med Chem (2021) 33:116019-116019. DOI 10.1016/j.bmc.2021.116019 · PubMed

Other PDB entries of the same protein (UniProt P22607 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 7DHL directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view. Have your own .pdb file? Open it in the online PDB file viewer.